Keryx Biopharmaceuticals Inc. | Key People and Executives
Jodie P. Morrison
Interim Chief Executive Officer & Director
Michael W. Rogers
Chairman
Steven C. Gilman
Independent Director
Michael Thomas Heffernan
Independent Director
Mark J. Enyedy
Independent Director
Kevin J. Cameron
Independent Director
Daniel Paul Regan
Independent Director
Jodie P. Morrison
Interim Chief Executive Officer & Director
Christine A. Carberry
Chief Operating Officer & Senior Vice President
Scott A. Holmes
CFO, Chief Accounting Officer & Senior VP
John F. Neylan
Chief Medical Officer & Senior Vice President
Melissa Bradford-Klug
Chief Business Officer & Senior Vice President
Amy B. Sullivan
Senior Vice President-Corporate Affairs
Daniel W. Olmstead
Vice President-Payer Access
Douglas Jermasek
Vice President-Marketing & Strategy
Lora L. Pike
Senior Director-IR & Communication
Lisa Fiering
Senior Director-Human Resources
Michael W. Rogers
Chairman
Steven C. Gilman
Independent Director
Michael Thomas Heffernan
Independent Director
Mark J. Enyedy
Independent Director
Kevin J. Cameron
Independent Director
Daniel Paul Regan
Independent Director
| Address |
12th Floor
Boston Massachusetts 02210
United States
|
|
Employees
|
- |
| Website |
http://www.keryx.com |
| Updated |
09/14/2018 |
| Keryx Biopharmaceuticals, Inc. engages in the manufacture, development, and commercialization of medicines for use in treating human diseases. Its product is the Auryxia tablet. The company was founded in October 1998 and is headquartered in Boston, MA. |
